Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-09-17
2009-06-16
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S357000, C514S365000, C514S396000, C544S393000, C544S400000, C546S330000, C548S204000, C548S205000, C558S404000, C558S414000, C558S431000, C558S434000
Reexamination Certificate
active
07547701
ABSTRACT:
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
REFERENCES:
patent: 6420364 (2002-07-01), Emmanuel et al.
patent: 6730671 (2004-05-01), Cywin et al.
patent: 7312211 (2007-12-01), Bekkali et al.
patent: 2004/0127426 (2004-07-01), Graupe et al.
patent: 2005/0014941 (2005-01-01), Black et al.
patent: 2005/0182096 (2005-08-01), Link et al.
patent: 2005/0240023 (2005-10-01), Bayly et al.
patent: 2006/0111440 (2006-05-01), Gauthier et al.
patent: 0 623 627 (1994-11-01), None
patent: WO99/24460 (1999-05-01), None
patent: WO 99/24460 (1999-05-01), None
patent: WO 00/51998 (2000-09-01), None
patent: WO 00/055125 (2000-09-01), None
patent: WO00/55144 (2000-09-01), None
patent: WO01/19796 (2001-03-01), None
patent: WO 01/19816 (2001-03-01), None
patent: WO01/19816 (2001-03-01), None
patent: WO 01/49288 (2001-07-01), None
patent: WO01/68645 (2001-09-01), None
patent: WO02/20485 (2002-03-01), None
patent: WO 02/069901 (2002-09-01), None
patent: WO02/098850 (2002-12-01), None
patent: WO03/029200 (2003-04-01), None
patent: WO03/075836 (2003-09-01), None
patent: WO 03/097617 (2003-11-01), None
patent: WO 2004/033445 (2004-04-01), None
patent: WO2004/083182 (2004-09-01), None
patent: WO 2004/108661 (2004-12-01), None
patent: WO2005/021487 (2005-03-01), None
patent: WO 2005/028429 (2005-03-01), None
patent: WO 2005/028454 (2005-03-01), None
patent: WO 2005/040124 (2005-05-01), None
patent: WO 2005/058348 (2005-06-01), None
patent: WO 2005/063742 (2005-07-01), None
patent: WO 02/074904 (2005-08-01), None
patent: WO 2005/074904 (2005-08-01), None
patent: WO 2006/034004 (2006-03-01), None
Volonterio, et al., Solution/Solid-Phase Synthesis of Partially Modified Retro-ψ [NHCH(CF3)]-Peptidyl Hydroxamates, Tetrahedron Letters, Feb. 23, 2001, pp. 3141-3144, vol. 42, Dipartimento di Chimica del Politecnico di Milano, Milan, Italy.
Greenspan, et al., Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design, J. Med. Chem., 2001, pp. 4524-4534, vol. 44, Amer. Chem Society, USA.
Bundgaard, et al. “A Novel Solution-Stable, Water-Soluble Prodrug Type for Drugs Containing a Hydroxyl or an NH-Acidic Group,” J. Med. Chem., 19898, vol. 32, No. 12, pp. 2503-2507.
Gong, Y., et al., “Convenient Substitution of Hydroxypyridines with Trifluoroacetaldehyde Ethyl Hemiacetal,” Journal of Heterocyclic Chemistry 2001, vol. 38, No. 1, p. 25-28.
Link John O.
Mossman Craig J.
Woo Soon H.
Zipfel Sheila M.
Sackey Ebenezer
Townsend and Townsend / and Crew LLP
ViroBay, Inc.
Wilson James O.
LandOfFree
Haloalkyl containing compounds as cysteine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Haloalkyl containing compounds as cysteine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Haloalkyl containing compounds as cysteine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4119492